Charles J. McDonald Professor Emeritus of Medical Science

A lifelong passion for helping others to succeed has resulted in a life of achievement for Dr. Charles McDonald. As an internationally recognized dermatologist/oncologist, Dr. McDonald has distinguished himself as a clinician, researcher, and educator-- and as a leader in his own community and well beyond it.

A pioneer in translational research, bringing proven research advances from the laboratory to application at the bedside or in the office, Dr. McDonald has been recognized in Best Doctors in America and America's Top Doctors for two decades. He has lectured at medical schools and conferences throughout the United States, Europe, Asia, and South America on the use of cancer drugs (cytotoxic and immune modulating agents) in non-cancerous systemic illnesses and skin diseases. His research and experience in these areas and in the development of safe and effective treatments for skin cancer and systemic autoimmune diseases have been published in some 200 scientific articles, book chapters and his own textbook.

As founding chairman of the Brown University Medical School's Department of Dermatology, Dr. McDonald has trained hundreds of medical students and Dermatology residents. He has been recognized by the Brown Medical School Alumni with their highest award for "teaching, mentoring, and contributions to the community both locally and nationally," the W.W. Keen Award. He has received a Distinguished Alumni Award from the Howard University College of Medicine; Howard University's Distinguished Postgraduate Achievement Award in the fields of Medicine and Community Service; and the Candle in Medicine Award from Morehouse College among many other academic citations.

Long active in the professional associations of his field, Dr. McDonald has served as president of the American Dermatological Association, as an officer of the American Academy of Dermatology, the Residency Review Committee for Dermatology, and as a board member of a number of related organizations in Dermatology and Medicine.

Dr. McDonald has been a member of the FDA Advisory Panel for Dermatology, a member of the first National Advisory Board for the National Institute for Arthritis, Musculoskeletal and Skin Diseases; and has served on numerous committees and study groups of the National Cancer Institute, the National Institute of General Medical Sciences, and the Institute of Medicine of the National Academy of Science.

A member of the Howard University Board of Trustees, Dr. McDonald is presently chair of the Advisory Board to the Cancer Center of the College of Medicine, and vice chair of the Board's Health Affairs Committee.

Active in the affairs of the American Cancer Society for three decades, Dr. McDonald became national president of the American Cancer Society in 1998, the only dermatologist ever to have held that post. During his tenure, Dr. McDonald led new efforts to improve diversity within the organization, coalesced national program efforts in childhood cancer, and spearheaded new program initiatives in prostate cancer in African American men.

Among local and regional positions of leadership, Dr. McDonald has been a member of the Rhode Island State Board of Education, a trustee of Citizens Bank, a trustee of the Providence Public Library, and a member of the group of founders of the Providence Health Centers. He served as a member of the executive board of the New England Regional Manpower Development Program of the U.S. Department of Health and Human Services. Dr. McDonald is currently a trustee of Lifespan, the largest health provider in southern New England.

In Rhode Island, Dr. McDonald has received awards for community service from the NAACP, the Hospital Association of Rhode Island, the Ministerial Alliance, the John Hope Settlement House, and the Urban League among other organizations.

Dr. McDonald was born in Tampa, Florida. He earned his undergraduate degree in Chemistry at North Carolina A&T University at age 19, followed by a Master's Degree in Zoology at the University of Michigan. In 1952, he joined the United States Air Force, serving as a flight officer and intelligence officer in the Strategic Air Command and achieving the rank of Major. In 1956, he entered Howard University Medical School, graduating first in his class in 1960. He completed residencies in internal medicine and dermatology; and a fellowship in clinical pharmacology and medical oncology at Yale University Medical School in 1966. Upon completion of his training, he joined the Yale Medical School faculty in Medicine and Pharmacology. In 1968, he moved to Providence to join the faculty of the Brown University Medical School.

Brown Affiliations

scholarly work

Geng A, Zeikus P, McBean J, McDonald CJ. Cutaneous Disorders in Skin of Color: Psoriasis in: Dermatology for Skin of Color. S. Taylor and A.P. Kelly, eds. McGraw Hill. Submitted February 2006.

1. Perlis CS, Pan TD, McDonald CJ. Cytotoxic Agents in: Comprehensive Drug Therapy in Dermatology. 2nd ed: S.E. Wolverton, W.B. Sauders Co. Submitted January 2006.

Malik MK, Regan L, Robinson-Bostom L, Pan TD, McDonald CJ. Proliferating multicentric reticulohistiocytosis associated with papillary serous carcinoma of the endometrium. J Am Acad Dermatol. 2005 Dec;53(6):1075-9.

34. Robinson-Bostom L, Pan TD, McDonald CJ. Alopecia and Other Cutaneous Complications, Clinical Oncology, third edition. Abeloff, Armitage, Niedenhuber, Kastan, McKenna (eds). Elsevier Churchill Livingstone, 2004, Chapter 40, p. 793-816.

McDonald CJ, Pan TD. Cytotoxic Agents in: Comprehensive Dermatologic Drug Therapy. Wolverton (editor). W.B. Saunders Company, Philadelphia, PA, 2001, p. 180-203.

33. McDonald CJ, Krause M, Dufresne RG, Robinson-Bostom L. Neoplasm of the Skin. Surgical Oncology: Contemporary Principles and Practice. Bland and Daly et al. Ed. Appleton and Lange, Stanford, CT, 2001:483-503.

McDonald CJ. Use of methotrexate in the treatment of psoriasis and other dermatologic disorders. In: Milestones in Drug Therapy, Methotrexate:. B.N. Cronstein and J.B. Bertino (eds). Birkhäuser Verlag, Basel., 2000, p. 109-123

Quevedo WC, Holstein TJ, Dyckman J, McDonald CJ, Isaacson EL, Inhibition of UVR Induced Tanning and Immunosuppression by Topical Application of Vitamins C and E to the Skin of Hairless Mice. Pigment Cell Research, April 2000, 13(2), 89-98.

74. Quevedo WC Jr., Holstein TJ, Dyckman J, McDonald CJ. The Responses of the Human Epidermal Melanocyte System to Chronic Erythemal Doses of UVR in Skin Protected by Topical Applications of a Combinatoin of Vitamins C and E. Pigment Cell Research, June 2000, 13(3):190-192.

31. McDonald CJ, Muglia JJ, Vittorio CC. Alopecia and Cutaneous Complications, In: Clinical Oncology, second edition. Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. (eds.) W.B. Saunders Company, Inc., New York, NY, 2000.

Quevedo WC Jr., Holstein TJ, Dyckman J, McDonald CJ. The Responses of the Human Epidermal Melanocyte System to Chronic Erythemal Doses of UVR in Skin Protected by Topical Applications of a Combinatoin of Vitamins C and E. Submitted to Pigment Cell Research Meeting. Short Communication. July 30, 1999.

McDonald CJ. Cancer Statistics, 1999: Challenges in Minority Populations. Guest Editorial. CA-A Cancer Journal For Clinicians, January/February 1999, Vol. 49, No. 1.

72. Muglia JJ, Pesce K, McDonald CJ, Skin Cancer Screening: A growing need. Surgical Oncology Clinics of North America. Donegan WL, Cady B (eds) W. B. Saunders Company. October, 1999; 8(4):735-745.

32. Quevedo WC Jr., Holstein TJ, Dyckman J, McDonald CJ, Isaacson EL: Inhibition of UVR-Induced Tanning by Topical Applications of Vitamins C and E to the Skin of Hairless Mice. Pigment Cell Research Meeting, June 25, 1999.

69. McDonald CJ. American Cancer Society Perspective on the American College of Preventive Medicine's Policy Statements on Skin Cancer Prevention and Screening. CA-A Cancer Journal For Clinicians July/August 1998; Vol 48, No. 4. p 229-231.

McDonald CJ, Fleming ID, Henson DE, Hutter RV, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, Yarbro JW, (eds.) American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 5th Edition. "Carcinoma of the skin (Excluding Eyelid, Vulva, and Penis)". Lippincott-Raven, 1997, Chapter 23, p157-161.

30. McDonald CJ.(ed.) Immunomodulatory and Cytotoxic Agents in Dermatology. New York, Marcel Dekker, Inc., 1997.

28. Calabresi P, McDonald CJ. Cutaneous Melanoma, in D.S. Fischer, M.D. (eds): Follow-up of Cancer. A Handbook for Physicians. Fourth Edition. Phila-New York, Lippincott-Raven, 1996, 9:94-95.

31. Quevedo. WC Jr, Holstein TJ, Dyckman J, McDonald CJ. Protection of Human Skin from UVR-induced damage by topical applications of a combination of vitamins C and E. Pigment Cell Research. Presented at the XVIth International Pigment Cell Conference, October 29-November 3,1996, Anaheim, California.

30. Quevedo WC Jr, Holstein J, Dyckman, McDonald CJ. Observations of the development of skin and the susceptibility of neonatal mice to melanoma induction by chemical carcinogens and ultraviolet light. (Poster Presentation) submitted for presentation at 1996 Northeast Regional Conference of the Society for Developmental Biology, May, 1996.

McDonald CJ. Drug Reactions and Interactions. What is the risk of immunosuppressive drug malignancy induction? (Abstract) Presented at the Annual American Academy of Dermatology Meeting. 1995-.

Quevedo WC, Holstein TJ, Dyckman J, McDonald CJ, Friedman DJ, Isaacson EL: Inhibition of UVR-Induced Tanning by Topical Applications of Vitamins C and E to the Skin of Hairless Mice. Submitted March 1995, Pan American Society for Pigment Cell Research, 6th Annual meeting, Kansas City, MO.

Schappell DL, Alper, JC, McDonald CJ: Treatment of Advanced Mycosis Fungoides and Sézary Syndrome with Continuous Infusions of Methotrexate Followed by Fluorouracil and Leucovorin Rescue. Arch Dermatol 1995;131(3):307-313.

27. McDonald CJ, Friedman DJ, Muglia JJ. Alopecia and Other Cutaneous Complications, in Abeloff, Armitage, Lichter and Niederhuber (eds): Clinical Oncology. New York, Churchill Livingston, 1995, chap 44, p753-770.

25. Quevedo WC, Holstein TJ, Dyckman J, Isaacson EL McDonald CJ. Age-Depended Changes in the Epidermal Melanocyte Populations of Mice. (Submitted) February 1995. 1995 Northeast Regional Conference of the Society for Developmental Biology.

67. Muglia JJ, McDonald, CJ: Skin Cancer Screening The PA’s role in early diagnosis. Physician Assistant. 1994;18(1):21-32.

McDonald, C.J.: Dermatological Effects of Mustard Agents and Lewisite, in CM Pechura, DP Rall (eds): Veterans At Risk: The Health Effects of Mustard Gas and Lewisite, Washington, D.C., National Academy Press, 1993, chap 9, p148-178.

Muglia JJ, McDonald CJ: Skin Cancer Screening in Women. The Female Patient. 1993;18:(11):13-22.

65. McDonald CJ: Status of Screening for Skin Cancer. Cancer, 1993; 72:3:1066-1070.

McDonald CJ. (reviewer) Cancer of the Skin, in D Friedman, Rigel DS, Kopf AW, Harris MN, Baker D, book review. WB Saunders, Phila., Postgraduate Medicine, 1991;(12)90:620.

25. Camishion G, Friedman D, McDonald CJ: Lyme Disease, J. Demis, In: Clinical Dermatology., Phila, J.P. Lippincott, Co, 1991, vol 2, Unit 7-6A1-5.

24. McDonald CJ. Cardiovascular complications of psoriasis, In: H.H. Roenigk, Jr., H.I. Maibach (eds): Psoriasis. New York, Marcel Dekker, Inc., 1991, p 97.

24. McDonald CJ. (reviewer), Systemic Drugs for Skin Diseases, in Wolverton and (eds): Book Review. Archives of Dermatology, 1991,Manuscript 91407.

28. McDonald CJ. Disorders of Pigmentation and Hair in Black Patients: Current Concepts. The Upjohn Co. Kalamazoo, MI 1991; p 1- 29.

27. McDonald CJ. Treatment of Psoriasis: Topical and Systemic. (Abstract) Presented at the Annual American Academy of Dermatology Meetings. 1991-

McDonald CJ: Cold Sore, Dermatology, Sun Lamp, Frostbite, Immersion Foot, Bed Sore. The World Book Encyclopedia. 18:988, 1990.

63. Wilkel C, McDonald CJ: Cyclosporine for resistant bullous erythema multiforme. Arch Dermatol 1990;126:397.

22. McDonald CJ: The Ectopic ACTH Syndrome. In: Crounse DJ, Dobson RG, McGuire RL, J. (eds): Clinical Dermatology, Demis, Harper & Row Publishers. 1990.

Abernathy DR, Alper J, Wiemann MC, McDonald CJ, Calabresi P: Oral 5-Fluorouracil in Psoriasis: Pharmacokinetic-Pharmacodynamic Relationships. Pharmacology; 1989;39(2):78-88.

23. McDonald CJ. The Use of Cytotoxic Drugs in Diseases with Dermatological Manifestations. Annual American Academy of Dermatology meeting. San Francisco, CA, December 1989.

McDonald CJ, Scott D. Dermatology in Black Patients, In: Dermatologic Clinics. WB SaundersCo. 1988;6:31, July.

Snook DL, McDonald CJ: The dermatologic manifestations of critical illness. Part 3: Disorders that may involve gram-negative bacteria. J Crit Illness 1988;3 (7): 73-85.

59. Snook DL, McDonald CJ: The dermatologic manifestations of critical illness. Part 2: Disorders caused by gram-positive organisms. J Crit Illness 1988; 3 (6): 93-108.

61. Snook DL, McDonald CJ: The dermatologic manifestations of critical illness. Part 4: Rocky Mountain spotted fever, herpes encephalitis, and DIC. J Crit Illness 1988;3(10):61-70.

20. Kpea NT, McDonald CJ. Cutaneous Infections in Blacks, In: Dermatologic Clinics, WB Saunders Co. 1988;6:489.

19. McDonald CJ. Structure and function of the skin: Are there differences between black and white skin? Dermatology in Black Patients, In: Dermatologic Clinics, WB Saunders Co. 1988;6:343.

McDonald CJ, Kelley AP. Dermatology of Black Skin, In: Demis DJ, Crounse RG, Dobson RL, McGuire (eds): Clinical Dermatology, Harper & Row Publishers, Revised, 1987.

McDonald CJ, Hayes HD, Rasmussen JE. Bacterial Infections of the Skin as Seen in Office Practice. Monograph, 1986.

McDonald CJ, Bentley-Phillips B. Keloids and Hypertrophic Scar, in Rook A, Parish L, Beare M, Practical Management of the Dermatologic Patient. Philadelphia, J.B. Lippincott Company, 1986.

17. McDonald CJ: Actinic Reticuloid, in Demis DJ, Crounse RG, Dobson RL, McGuire J. (ed): Clinical Dermatology, Harper & Row Publishers. Revised 1986.

16. Bentley - Phillips, B., McDonald CJ: Pseudofolliculitis barbae, in Rook A, Parish L, Beare M (eds): Practical Management of the Dermatologic Patient. Philadelphia, J. B.Lippincott Company , 1986.

21. Alper JC, Kegel MF, Wiemann MC, McDonald CJ, Calabresi PC. Rationally designed combination chemotherapy for advanced mycosis fungoides. Presented at the III World Conference on Clinical Pharmacology & Therapeutics on July 27 - August 1, 1986 in Stockholm, Sweden.

Cummings FJ, McDonald CJ, Calabresi P. Malignant Melanoma. In: Calabresi, Schein, Rosenberg (eds): Medical Oncology. Macmillian Publishing Company, Inc., 1985.

McDonald CJ: Use of cytotoxic drugs in dermatologic disease II. J Am Acad Dermatol 1985;12:965-975.

McDonald CJ: Cytotoxic agents for use in dermatology I. J Am.Acad Dermatol 1985;12:753-775.

57. Alper JC, Wiemann MC, Rueckl FS, McDonald CJ, Calabresi PC: Rationally designed combination chemotherapy for the treatment of patients with recalcitrant psoriasis. J Am Acad Dermatol 1985;13:567-577.

12. McDonald CJ, Calabresi P. Dermatological Neoplasms, In: Calabresi, Schein, Rosenberg (eds): Medical Oncology. Macmillan Publishing Company, Inc, 1985.

14. McDonald CJ. Cardiovascular Complications of Psoriasis, In: Roenigk, Maibach (eds):Psoriasis. New York, Marcel Decker, Inc., 1985, p 79-93.

20. Alper JC, Kegel MF, Wiemann MC, Crabtree G.W, McDonald CJ, Calabresi PC. A new form of combination chemotherapy for advanced mycosis fungoides. Clinical Research 1985. Presented at the AAD Summer Session in San Diego on June 20 - 21, 1985.

Wiemann MD, Alper JC, Rueckl FV, McDonald CJ, Calabresi P. Highly effective and safe therapy for resistant psoriasis with low-dose 5-Fluorouracil. Clinical Research 1983;vol 31.

McDonald CJ: Polyamines in psoriasis. J Inves Dermatol 1983;81:385-387.

Borkovic SP, Alper JC, McDonald CJ: Stimulation of pigmentation of melanoma cells by trimethyl psoralen in the absence of ultraviolet irradiation. Br J Dermatol 1983;108:525-532.

McDonald CJ: Raynaud's syndrome. Dermatol Clin 1983;1:493-504.

McDonald CJ: Cholinergic and cold urticarious. Postgrad Med 1982;71:216.

11. McDonald CJ. Special requirements in cosmetics for people with black skin, in Frost P, Horowitz S (eds): Principles of Cosmetics for Dermatologist. Mosby 1982, pp 302-304.

18. Alper JC, Wiemann MD, Rueckl FV, McDonald CJ, Calabresi PC. Combination chemotherapy for recalcitrant psoriasis. Association of American Physicians, January 1982. Presented at the National Clinical Dermatology Conference, April 1982.

McDonald CJ: The uses of systemic chemotherapeutic agents in psoriasis, in Baden H.(ed.): Pharmacology and Therapeutics Part A: Chemotherapy Toxicology and Metabolic Inhibitors Great Britain, Press Ltd. Pergamon, 1981.

McDonald CJ: Cutaneous manifestations of systemic disease. Postgrad Med 1981;69(5):132-49.

McDonald CJ: The uses of systemic chemotherapeutic agents in psoriasis Pharmacy Ther 1981;14:1-24.

McDonald CJ. A Treatment plan for itching hands in young women. PostGraduate Medicine. 1980;68:(6)24.

McDonald CJ: Immunosuppressive therapy in collagen vascular disease. Cutis. 1979;23:441.

McDonald CJ: Sarcoidosis. Weekly Update:Dermatology 1979;29(1);1.

Herstoff JK, McDonald CJ: Rhinophycomycosis and Entomophthora: case report and review of the literature. Arch Dermatol 1978;114:1674-1678.

1978;62(7):1009-14.

Spatz S, Rudnicka A, McDonald CJ: Mycophenolic acid in psoriasis. Br J Derm 1978;

Kravitz P, McDonald CJ: Topical nitrogen mustard induced carcinogenesis. Acta Dermato- venereal 1978;8:421-425.

McDonald CJ, Calabresi P: Psoriasis and thromboembolic disease. Br J Dermatol 1978;99:469.

McDonald CJ, DeFeo JJ, George FJ, Johnson RD, Knowles DG. Dermatology Roundtable Discussion on Skin Diseases Seen Among Athletes. Schering, Corp., 1978.

9. McDonald CJ. Psoriasis. World Book Encyclopedia, 1978.

McDonald CJ. Syphilis, in Conn HF, Conn RB, (eds): Current Diagnosis, 5th Edition. W.B. Saunders Co., Phil. 1977, pp 218-225.

McDonald CJ. Dermatology of Black Skin. Practice of Medicine, Harper & Row Publishers, Maryland. 1977, vol 1, chap 64, pp. 1-20.

Doolittle CH, McDonald CJ, Calabresi: Pharmacologic studies of CNS toxicity in patients with psoriasis treated with Azaribine by high pressure liquid chromatography. J Lab Clin Med 1977; 90:773.

17. McDonald CJ, Knowles KG, DeFeo JJ, George FJ, Johnson RD. Skin Diseases Seen Among Athletes. Dermatology Roundtable Discussion. December 3, 1977.

16. Kravitz P, McDonald CJ. Topical nitrogen mustard induced carcinogenesis. Presented at the Annual Meeting of the American Medical Association, June 1977.

Quevedo WC Jr, McDonald CJ, Dyckman J, Bienieki TC, Fleishman RD, Hostein TJ. The epidermal melanocytes of the mongolian gerbil: Their postnatal development and response to carcinogens, in Riley V (ed.): Pigment Cell, Darger Publishing Company, Basel, 1976, vol 3, pp. 357-366.

McDonald CJ: Learn to recognize mycosis fungoides early. Consultant. 1976;16:170.

Campo AG Jr, McDonald CJ: Successful treatment of acrodermatitis enteropathica with zinc sulfate. Arch Dermatol 1976;112:687-689.

Guidelines for use of Azaribine in the treatment of psoriasis. Prepared by a Subcommittee of the Task Force on Psoriasis, National Program for Dermatology. Arch Dermatol 1976;112:228-390.

McDonald CJ: Some thoughts on black vs. white skin. Int J Dermatol 1976;15:427-430.

7. McDonald CJ. Dermatology of Black Skin, in Demis DJ, Crounse RG, Dobson RL, McGuire J, (eds): Clinical Dermatology, Harper & Row Publishers, 1976. Revised 1986.

6. McDonald CJ: Psoriasis, in Howard F. Conn (ed): Conn's Current Therapy. 28th Edition. Phil, WB Saunders Company, 1976, pp. 142-150.

Campo AG, Jr, Colavecchio L, McDonald CJ. Inverse T/B ratios in vitiligo and psoriasis. Clinical Research 1975;23:227.

McDonald CJ, Kelly AP. Dermatology Venereology, in Williams R, (ed): Black Related Diseases. McGraw-Hill Book Publishers, 1975, pp. 513-591.

McDonald CJ: Chemotherapy of Psoriasis. Int J Dermatol. 1975;14:563-574.

Mitchell GW, Lichtenfeld PJ, McDonald CJ: Myasthenia gravis and scleroderma: An unusual combination of diseases. JAMA 1975; 233:531.

Calabresi P, Doolittle CH, Heppner GH, McDonald CJ: Nucleotide analogs in the treatment of non-neoplastic diseases. Ann. N.Y. Academy of Sciences 225: 1975;190-201.

4. McDonald CJ. Psoriasis – Azaribine, in Madden S (ed): Current Dermatologic Management .St. Louis, Mosby Company, 1975, pp. 263-264.

14. Spatz S, Rudnicka A, McDonald CJ. Mycophenolic acid in psoriasis. Presented at the Annual Meeting of the American Medical Association, June 1975.

13. Herstoff JK, McDonald CJ. Subcutaneous Phycomycosis. Presented at the Annual Meeting of the American Medical Association, June 1975.

McDonald CJ, Calabresi P. Combination chemotherapy in mycosis fungoides. Presented at the XI International Cancer Congress, October 1974.

McDonald CJ: Cutaneous uses of the anti-proliferative drugs. Clin Pharm Therap 1974;16:934-939.

McDonald CJ: The contributions of the Tuskegee Study to medical knowledge. J Natl Med Assoc 1974;66:1-7.

McDonald CJ: Psoriasis. Minn Med 1974;47:813-820.

2. McDonald CJ, Kelly AP. Lymphogranuloma venereum, In: Conn HF, Conn RB, Jr (eds): Conn's Current Diagnosis, 4th Edition. W.B. Saunders Co., 1974, pp. 111-115.

11. McDonald CJ, Calabresi P. Psoriasis and Occlusive Vascular disease. Presented at the Annual Meeting of the American Society for Clinical Investigation, May 1974.

McDonald CJ: Dermatological problems in black skin. Progress in Dermatology 1973;7:15-20.

McDonald CJ: Tried and true -- a new therapy in psoriasis. Consultant 1973;13:64.

Wiley CJ, Williams WW, McDonald CJ: The effects of the epidermal chalone on DNA synthesis in mammalian epidermal cells. J Inves Derm 1973;60:160-165.

McDonald CJ, Los L: Studies on the in-vitro incorporation of 3H-thymidine, 3H-uridine, and 3H-leucine into mammalian epidermal cells. Dermatological 1973;147:391-398.

Sexually Transmitted Diseases. Springfield, IL, 1973, p 148.

McDonald CJ, Markowitz S, Fethiere W, Kerzner M: Occupational Acro-osteolysis. Arch Derm 1972;106:219-223.

Olvey SK, McDonald CJ: The in vitro cell cycle of adult mammalian epidermis: A preliminary study. J Invest Derm 1972;58:175.

10. Doolittle CH, McDonald CJ, Calabresi P. Pharmacological studies of CNS toxicity in patients with psoriasis treated with Azaribine. Clinical Research. 1972;20:407. Presented at the Annual Meeting of the American Federation of Clinical Research, April 1972.

McDonald CJ, Fleischmajer R. Protocol and clinical results of multicenter study: Placebo vs. Desonide. Presented at the Tridesilon Clinical Conference. November 1971.

McDonald CJ: Review Article: Chemotherapeutic approaches to dermatological diseases. J Punj Med 1971;20:219-229.

McDonald CJ, Calabresi P: Azaribine for mycosis fungoides. Arch Derm 1971;103:158-167.

8. McDonald CJ, Los L. Biosynthetic changes in the cell cycle of the mammalian epidermal cells. Clinical Research. 1971;29:363. Presented at the Annual Meeting of the American Federation of Clinical Research, May 1971.

7. Olvey SK, McDonald CJ. The mitotic cycle of the mammalian epidermal cell. J Invest Derm 1971;56:405. Presented at the Annual Meeting of the American Federation of Clinical Research, May 1971.

McDonald CJ, Quevedo, WC, Bienieki TC, Fausto N. Role of melanocytes in response of skin of Mongolian gerbils to chemical carcinogens. Proc. of VII International Pigment Cell Conference. Presented at the VII International Pigment Cell Conference, September 1970.

McDonald CJ: Immunocytes, autoimmune response and suppression. J Nat Med Assn 1970;224-226.

McDonald CJ, Quevedo WC Jr., Bienieki TC, Fausto N: Role of melanocytes in responses of the skin of Mongolian gerbils to chemical carcinogens. J Invest Derm 1970;54:92-93.

McDonald CJ, Calabresi P. Azaribine in mycosis fungoides. Presented at the Annual Meeting of the American Society for Clinical Oncology, March 22, 1969.

Howard RO, McDonald CJ, Dunn B, Creasey WA: Experimental chlorpromazine cataracts. J Invest Ophthalmology 1969; 8:413-412.

Mroueh A, McDonald CJ: The effect of 6-azauridine on spermatogenesis in laboratory animals. J. Leb. Med 1969;22:129-138.

McDonald CJ, Bertino J: Parenteral methotrexate in psoriasis. Arch Derm 1969;100:655.

McDonald, CJ: Mycosis fungoides: a malignant cutaneous lymphoma. Conn Med 1969;33:37.

McDonald CJ: Skin manifestations of malignancy. Derm Digest 1969;8:69.

5. McDonald CJ. High dose Methotrexate and leucovorin in refractory mycosis fungoides and psoriasis. Clinical Research. 1969;17:276.

4. McDonald CJ. High dose methotrexate for psoriasis and mycosis fungoides. J Invest Derm, April 1969.

McDonald CJ, Bertino J: Parenteral methotrexate for psoriasis. Lancet I 1968; (7547):864.

McDonald CJ, Calabresi P, DeConti AB: Triacetyl 6- azauridine in mycosis fungoides. Proceedings of XIII International Congress of Dermatology. (ed.) W. Jadasson and C.G. Shirren. Springer-Verlag, Berlin. 1968;2:739.

McDonald CJ, Snell RS, Lerner AB: Chlorpromazine oculocutaneous pigmentation. J Invest Derm 1967; 49:39.

McDonald CJ: Anti-tumor drugs in diseases of the skin. Conn Med 1967;31:416.

McDonald CJ, Creasey WA, Howard RO: Chlorpromazine toxic ocular manifestations in guinea pigs. Clinical Research 1966;14:492.

McDonald CJ, Lerner AB: Atopic dermatitis and persistent lactation. Arch Derm 1966;93:174.

McDonald CJ: Clinical and laboratory diagnosis in disorders of pigmentation. J Natl Med Assoc 1966;58:410.

2. McDonald CJ, Creasey WA, Howard RO. Chlorpromazine toxic ocular manifestation in guinea pigs. Clinical Research 1966;14:492.

J Natl Med Assoc 1965;57:26.

McDonald CJ, Snell RS, Lerner AB: The effect of laser radiation on mammalian epidermal melanocytes. J Invest Derm 1965;45:110.

1. McDonald CJ. The effect of laser radiation on mammalian epidermal melanocytes. Clinical Research 1965;13:230.

McDonald CJ, Barile AK: Acute syphilitic nephrosis: Case report. Arch Int Med 1963;3:228.

Kelly AP, McDonald CJ. Granuloma inguinale, In: Conn HF, Conn RB, Jr (eds): Conn's Current Diagnosis, 4th Edition. WB. Saunders Company, pp. 181-183.

McDonald CJ. Systemic complications of gonococcal infection, In: Nicholas L, Thomas CC (eds):

Snook DL, McDonald CJ: The dermatologic manifestations of critical illness. Part 1: Disorders that may be of noninfectious origin. J. Crit. Illness. l988;3(5):9-22.

McDonald CJ, Bertino JR: Treatment of mycosis fungoides lymphoma: effectiveness of infusions of methotrexate followed by oral citrovorum factor leucovorin. Cancer Treatment Reports.

98:429.

McDonald CJ: Antineoplastic agents in the treatment of psoriasis. Medical Times. 105

McDonald CJ, Turner RW: Lupus erythematosus, systemic scleroderma and dermatomyositis.

71. Mettlin CJ, Murphy GP, McDonald CJ, Menck HR. The National Cancer Data Base (NCDB) Report on Increased Use of Brachytherapy for Treatment of Prostate Carcinoma in U.S. Cancer. A Journal of the American Cancer Society and The American College of Surgeons Commission on Cancer.

TEXTBOOKS AND CONTRIBUTIONS TO TEXTBOOKS AND MONOGRAPHS

PUBLICATIONS SUBMITTED OR IN PREPARATION

ABSTRACTS AND SHORT REPORTS

research overview

Charles McDonald, Professor of Medical Science and Chairman, has a number of research interests including: diagnosis and treatment of lymphomas of skin; chemotherapy of psoriasis; and cytotoxic and immunosuppressive agents of use in inflammatory, autoimmune and blistering skin diseases.

research statement

Charles McDonald, Professor of Medical Science and Chairman, has a number of research interests including: diagnosis and treatment of lymphomas of skin; chemotherapy of psoriasis; and cytotoxic and immunosuppressive agents of use in inflammatory, autoimmune and blistering skin diseases.

funded research

No present funding at this time.